iiinova — where your digital self keeps evolving

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 04/12/2025

We have a spot open for training in our program! Come join our family in Philly. If you want to become a fantastic clinical ID doc in a vibrant and dynamic medical center located in the greatest city (Go bird!) contact us through our DM or alejandro.delgado@jefferson.edu @febrilepodcast.com

012

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 12/09/2025

And that's a wrap for this week! Excited to hang out with applicants and keep learning. Good luck and have fun, from all us at Jefferson Einstein.

010

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 12/09/2025

Final case: Patient with MSSA bacteremia who has difficult to clear MSSA bacteremia with no obvious drainable abscess. Pending TEE, should we be using combo therapy? Absolutely maybe perhaps totally! Lets look at the data.

100

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 12/09/2025

journals.asm.org/doi/10.1128/... This paper breaks down the risk profile of different biologics for reactivation. As usual, TNF inhibitors are at the top of risk. B cell agents carry a minimal to non significant increase in risk Remember Hep B though!

100

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 12/09/2025

Next up. Patient with SLE presents to clinic after having positive Quantiferon in preparation for biologics, specifically Belimumab.What is the risk of reactivation of latent TB in patients starting B cell depleting therapy? I gotchu fam

100

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 12/09/2025

The clinical response to Gram stain–guided antibiotic therapy was noninferior to that of guideline-based antibiotic therapy (76.7% vs 71.8%). Gram stain–guided antibiotic therapy reduced the use of antipseudomonal agents and anti–methicillin-resistant Staphylococcus aureus agents. Nice!

100

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 12/09/2025

Recruitment has started! Case conference today was fantastic as always. A few snippets: 1) Patient in the ICU who develops nosocomial PNA/VAP with areas of necrosis. Can you use a gram stain to guide empiric antibiotics? Why, glad you asked! Enter GRACE-VAP study

120

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 07/08/2025

Looks like the team has been busy stamping out disease! Come join us next July! Find out why our division is the most nominated for teaching awards by our trainees

110

Jefferson Einstein Infectious Diseases Fellowship @einsteinphillyid.bsky.social · 29/07/2025

Come train with us at Jefferson Einstein Philadelphia! Engage with seasoned faculty in a collegiate and stimulating environment based in the greatest city in the US

010